We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

ING:NYSEING Group, N.V. Analysis

Data as of 2026-05-23 - not real-time

$30.50

Latest Price

6/10Risk

Risk Level: Medium

Executive Summary

ING's stock is trading at $30.5, comfortably above its 20‑day SMA (29.33) and 50‑day SMA (27.97), indicating a bullish price bias. The 14‑day RSI sits at 61.7, suggesting continued upward momentum without being overbought. MACD shows a bullish crossover (line 0.585 above signal 0.530) with a positive histogram, reinforcing the technical upside. The price is holding above the key support of $27.54 and approaching the resistance at $30.90, leaving limited downside risk. Fundamental metrics reveal a forward PE of 9.67 versus an industry average of 16.75, positioning ING as potentially undervalued. The dividend yield of 4.15% coupled with a payout ratio under 50% underscores a sustainable income stream.
Recent Q1 2026 results beat expectations, delivering €1.56 bn net profit, a CET1 ratio of 13% and prompting a €1 bn share buyback, which bolsters confidence in capital strength. Revenue grew 2.9% YoY, and operating margin remains robust at 41.7%, highlighting solid profitability. Volatility over the past 30 days is elevated at ~30% and beta of 1.24 indicates higher sensitivity to market swings, suggesting moderate risk. The Fear & Greed Index reads “Extreme Greed” (91.6), reflecting strong market optimism that could sustain price momentum. With a market cap of $87.5 bn and stable trading volume, liquidity is ample, reducing execution concerns. Overall, the combination of bullish technicals, attractive valuation, and resilient earnings supports a cautiously optimistic outlook.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • Bullish technical indicators (SMA, RSI, MACD)
  • Strong Q1 earnings beat and share buyback
  • High dividend yield with sustainable payout

Medium Term

1–3 years
Positive
Model confidence: 7/10

Key Factors

  • Undervalued valuation relative to industry PE
  • Robust operating margin and revenue growth
  • Attractive dividend yield supporting total return

Long Term

> 3 years
Positive
Model confidence: 8/10

Key Factors

  • Sustainable dividend backed by solid capital ratios
  • Consistent profitability and cash generation
  • Long‑term upside potential reflected in analyst price targets

Key Metrics & Analysis

Financial Health

Revenue Growth2.90%
Profit Margin34.23%
P/E Ratio12.0
ROE16.57%
ROA0.78%
P/B Ratio1.5
Industry P/E16.8

Technical Analysis

TrendBullish
RSI61.7
Support$27.54
Resistance$30.90
MA 20$29.33
MA 50$27.97
MA 200$26.89
MACDBullish
VolumeStable
Fear & Greed Index91.61

Valuation

Target Price$31.13
Upside/Downside2.08%
GradeUndervalued
TypeValue
Dividend Yield4.15%

Risk Assessment

Beta1.24
Volatility29.76%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskMedium
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.